Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells




StemScreen®-2 is a proprietary high throughput screen currently in development. StemScreen®-2 takes advantage of a landmark discovery that cancer cell lines harbor CSCs. This technology enables the development of high throughput screens for compounds that target CSCs.
Copyright 2012 - Stemline Therapeutics, Inc. All rights reserved
Stemline